Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Profiling gut bacteria in patients with severe alcoholic hepatitis

Official title: Intestinal Microbiota Profiling in HAA Patients

Run by Centre Hospitalier Universitaire, Amiens · NCT06159244 · Data updated 2026-11-12

This study is testing if the types of gut bacteria in patients with severe alcoholic hepatitis can help predict how well they respond to corticosteroid treatment, with or without fecal microbiota transplantation.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment200 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens, Picardie)
StatusRecruiting
StartedNovember 15, 2023
Main results expectedNovember 2028
Study endsNovember 2028
Registry record updatedMay 25, 2025
Trial IDNCT06159244 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 75 with a confirmed diagnosis of severe acute alcoholic hepatitis and a high Maddrey score.

Probably not a fit

Patients with other liver diseases, uncontrolled liver complications, or those outside the age range may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the intestinal microbiota profiles of patients suffering from severe acute alcoholic hepatitis. It aims to identify specific microbiota signatures that may correlate with treatment responses to corticosteroids, either alone or in combination with fecal microbiota transplantation (FMT). By analyzing these profiles, the study seeks to enhance understanding of how gut bacteria influence the effectiveness of corticosteroid therapy in this patient population. The ultimate goal is to provide clinicians with rapid and simple tools to predict treatment outcomes based on microbiota composition.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for patients with severe alcoholic hepatitis, potentially enhancing survival rates.

How similar studies have gone: While the specific approach of profiling intestinal microbiota in this context may be novel, there is growing interest in the role of gut bacteria in liver diseases, suggesting potential for success based on related research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged from 18 to 75 years, having :
* Heavy drinker with Maddrey Score ≥ 32 : PT(second)-PT(control)x4.6+Bilirubine (mg/dl)
* Histological confirmed Alcoholic hepatitis
* Personal consent signed to the trial
* No exclusion criteria

Exclusion Criteria:

* Age \< 18 years and/or \> 75 years,
* Pregnancy or lactating females,
* No personal consent
* Other causes of liver disease: chronic hepatitis B (antigen HBs positive), hepatitis C (HCV RNA positive), acetaminophen hepatotoxicity, biliary obstruction, autoimmune hepatitis, primary biliary cholangitis, primary sclerosis cholangitis, alpha 1 antitrypsine deficiency, and Wilson disease.
* Uncontrolled liver complications:
* Upper gastrointestinal bleed by portal hypertension (4 days required for stable condition)
* Active sepsis (4 days required for stable condition)
* Patient currently treated by antibiotic
* Concomitant Liver cancer (HCC) or extrahepatic malignancy
* Type 1 hepatorenal syndrome (HRS) or renal failure defined as a serum creatinine \>221 μmol/L (\>2.5 mg/dL) or the requirement for renal replacement therapy
* Grade 4 Hepatic Encephalopathy (HE) by West Haven criteria
* Individuals dependent on inotropic (eg, epinephrine or norepinephrine) or ventilatory support (ie, endotracheal intubation or positive-pressure ventilation)
* Disseminated intravascular coagulation
* Intestinal paralysis
* History of liver transplantation

Other general diseases or severe conditions:

* HIV disease
* Intestinal paralysis
* Intestinal inflammatory disease (Crohn or Ulcerative colitis)
* Clostridium difficilae infection
* Clinical suspicion of pneumonia
* Uncontrolled sepsis
* Acute Alcoholic pancreatitis
* Noncontrolled alcohol withdrawal syndrome
* Cardiac or respiratory bad conditions

Where it's running

  • CHU Amiens Picardie
    Amiens, Picardie, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.